Background:
We mvestigated whether most commonly used lipid-lowering therapiesstatins and fibrate improve nitric oxide (NO) bioactivity and reduce serological markers of inflammation and whether these therapies-induced reduction in markers of inflammation is mediated by improvement in NO bioactivity or lipoprotein changes.
Methods
For 8 weeks, we administered simvastatin 20 mg or fenofibrate 200 mg daily to each 27 randomly selected patients with hypercholesterolemia and coronary artery disease or pure hypertriglyceridemia, respectively. Data= mean&EM and median (25%. 75%).
Results
Both therapies signiftcantly changed lipoprotein levels from the respective baseline levels. As expected, simvastatin significantly lowered TC and LDL-C more and fenofibrate increased TG and HDL-C more than either therapy. Simvastatin 
The plasma t-Hcys was higher in patients than in controls (PcOOl). It was also higher in MTHFR 677 lT, than in 677 CC and 677 CT, II? controls, but not in patients. Cystatin-C, marker of glomerular filtratton was the single independent determinant of increased t-Hcys of patients (P = 0.04), m multiple regression analysts. taking also into account folates. vitamin 86 and 812, cystationme and methylmalonic acid. The upper quartile of t-Hcys (>10.5 wmol/l) and MTR 2756 AGIGG genotype were significant independent risk factors of coronary artery disease with respective Odds ratios of 3.0 (95 % Cl: 1.7-5.3. P=O.O002) and of 2.8 (95% Cl: 1.3-6.0, P=O.Olll).
By contrast. the combmation of MTHFR 677 CT/MTR 2756 AG, MTHFR 677 CC/1298 AC and MTHFR 677 CT/ 1298AA were protective, with Odd ratios of 0.13, 0.48 and 0.34, respectively.
Conclusion:
MTR 2756 AG genotype considered alone is a potent risk factor of coronary artery disease while it becomes protective in association with MTHFR 677 CT genotype.
Increase of t-Hcys IS rather Influenced by glomerular filtration than by genetic and nutritlonal factors. Our study Illustrates the necessity to evaluate the relative risk generated by t-Hcys by considering the interaction of all genetic nutritional and metabolic potential determinants rather than by evaluating independently each one. 
Methods:
We studied 10 men with newly diagnosed OSA who were free of other diseases, had never been treated for OSA, and were taking no medications. Measurements were made before and after 5 hours of untreated OSA, and again after 4 hours of acute continuous positive allway pressure &PAP) treatment. We compared methyl&d arginine measurements I" these patients to measurements obtained at similar times in 10 matched control sublects.
Results: Baseline ADMA and L-NMMA levels before sleep were similar in the OSA and control group. ADMA and L-NMMA levels increased significantly (from 13.9iO. We conducted a nested 1:2 cazcontrol study in the Women's Health Study cohort. We Identified 464 cases of incident myocardial infarction, stroke, or coronary revascularization and 928 controls who remained free of cardiovascular events at the time of case diagnosis. The mean follow-up was 7 years.
Results: 136 of the overall study population had a history of diabetes at enrollment or an overtly elevated baseline HbAlc (~-6.40%) and were excluded from the primary analyses. Among women without diabetes or an elevated baseline HbAlc, baseline mean levels of HbAlc were significantly higher among future cardiovascular cases than controls (5.47% * 0.27 vs 5.37% t 0.22; p<O.OOOl). The crude relative risks (RR) of incident cardiovascular events for increasing quartiles of HbAlc were 1, 0.98, 1.33, and 2.25 (95% Cl for highest vs lowest quartile 1.59-3.18). HbAlc levels were significantly correlated with several other traditional cardiovascular risk factors, including age, body mass index, systolic blood pressure, C-reactive protein, and total cholesterol: high density lipoprotein-cholesterol ratio. In fully adjusted models the predictive effect of HbAlc was attenuated and not significant (RR = 1 .OO for top vs bottom quartile, 95% Cl 0. 65-l .54 The plasma redox state of glutathlone (Eh GSH/GSSG) has been shown to be a novel marker of oxldative stress in humans. We hypothesized that in Eh GSH/GSSG and endothelial dysfunction would both correlate with the presence of early atherosclerosis in humans.
We evaluated brachial artery flow-mediated dilation (FMD) and common carotid artery intlma media thickness (CIMT) in 40 adults with no clinical atherosclerotic disease. Plasma glutathione (GSH), oxidized glutathione (GSSG). Eh GSH/GSSG, and FMD were correlated with CIMT.
Results: There was an inverse correlation between CIMT and FMD (r = -0.43, p-0.005).
